Fabian Theis says that, although some large pharmaceutical companies promote experiment-computation integration as a general theme, there are still few examples of repeated cycles linking experiments and computational models.

“You know, sort of the, the lab and the loop is really working out. And even though some big pharma has been putting this out as sort of a general, general big theme, there's not many examples yet where really people do multiple loops of this integration of an experiment, a computation model, then going back whether this is now two-person or one, right?”